These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 31424670

  • 1. Serum miR-1301-3p, miR-335-5p, miR-28-5p, and their target B7-H3 may serve as novel biomarkers for colorectal cancer.
    Wang L, Zhao Y, Xu M, Zhou F, Yan J.
    J BUON; 2019; 24(3):1120-1127. PubMed ID: 31424670
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Expression levels of miR-143-3p and -424-5p in colorectal cancer and their clinical significance.
    Sahami-Fard MH, Kheirandish S, Sheikhha MH.
    Cancer Biomark; 2019; 24(3):291-297. PubMed ID: 30883340
    [Abstract] [Full Text] [Related]

  • 4. The expression and clinical significance of B7-H3 and miR-145 in lung cancer patients with malignant pleural effusion.
    Huang L.
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6759-6766. PubMed ID: 32633367
    [Abstract] [Full Text] [Related]

  • 5. Clinical correlation of B7-H3 and B3GALT4 with the prognosis of colorectal cancer.
    Zhang T, Wang F, Wu JY, Qiu ZC, Wang Y, Liu F, Ge XS, Qi XW, Mao Y, Hua D.
    World J Gastroenterol; 2018 Aug 21; 24(31):3538-3546. PubMed ID: 30131660
    [Abstract] [Full Text] [Related]

  • 6. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.
    Ozcan O, Kara M, Yumrutas O, Bozgeyik E, Bozgeyik I, Celik OI.
    Tumour Biol; 2016 May 21; 37(5):6637-45. PubMed ID: 26643896
    [Abstract] [Full Text] [Related]

  • 7. Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c.
    Nygren MK, Tekle C, Ingebrigtsen VA, Mäkelä R, Krohn M, Aure MR, Nunes-Xavier CE, Perälä M, Tramm T, Alsner J, Overgaard J, Nesland JM, Borgen E, Børresen-Dale AL, Fodstad Ø, Sahlberg KK, Leivonen SK.
    Br J Cancer; 2014 Apr 15; 110(8):2072-80. PubMed ID: 24577056
    [Abstract] [Full Text] [Related]

  • 8. Tissue miR-200c-3p and circulating miR-1290 as potential prognostic biomarkers for colorectal cancer.
    Kang E, Jung SC, Nam SK, Park Y, Seo SH, Park KU, Oh HK, Kim DW, Kang SB, Lee HS.
    Sci Rep; 2022 Feb 10; 12(1):2295. PubMed ID: 35145164
    [Abstract] [Full Text] [Related]

  • 9. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
    Zhang H, Zhu M, Shan X, Zhou X, Wang T, Zhang J, Tao J, Cheng W, Chen G, Li J, Liu P, Wang Q, Zhu W.
    Gene; 2019 Mar 01; 687():246-254. PubMed ID: 30458288
    [Abstract] [Full Text] [Related]

  • 10. Colorectal cancer cell-derived extracellular vesicles transfer miR-221-3p to promote endothelial cell angiogenesis via targeting suppressor of cytokine signaling 3.
    Dokhanchi M, Pakravan K, Zareian S, Hussen BM, Farid M, Razmara E, Mossahebi-Mohammadi M, Cho WC, Babashah S.
    Life Sci; 2021 Nov 15; 285():119937. PubMed ID: 34508764
    [Abstract] [Full Text] [Related]

  • 11. Downregulation of Serum miR-133b and miR-206 Associate with Clinical Outcomes of Progression as Monitoring Biomarkers for Metastasis Colorectal Cancer Patients.
    Wanram S, Klaewkla N, Pinyosri P.
    Microrna; 2024 Nov 15; 13(1):56-62. PubMed ID: 38231064
    [Abstract] [Full Text] [Related]

  • 12. Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer.
    Li H, Dai S, Zhen T, Shi H, Zhang F, Yang Y, Kang L, Liang Y, Han A.
    Eur J Cancer; 2014 Apr 15; 50(6):1207-21. PubMed ID: 24412052
    [Abstract] [Full Text] [Related]

  • 13. Overexpression of B7-H3 in CD133+ colorectal cancer cells is associated with cancer progression and survival in human patients.
    Bin Z, Guangbo Z, Yan G, Huan Z, Desheng L, Xueguang Z.
    J Surg Res; 2014 May 15; 188(2):396-403. PubMed ID: 24630518
    [Abstract] [Full Text] [Related]

  • 14. MiRNAs as molecular biomarkers in stage II egyptian colorectal cancer patients.
    Bahnassy AA, Salem SE, El-Sayed M, Khorshid O, Abdellateif MS, Youssef AS, Mohanad M, Hussein M, Zekri AN, Ali NM.
    Exp Mol Pathol; 2018 Dec 15; 105(3):260-271. PubMed ID: 30213464
    [Abstract] [Full Text] [Related]

  • 15. miR-34a induces immunosuppression in colorectal carcinoma through modulating a SIRT1/NF-κB/B7-H3/TNF-α axis.
    Meng F, Yang M, Chen Y, Chen W, Wang W.
    Cancer Immunol Immunother; 2021 Aug 15; 70(8):2247-2259. PubMed ID: 33492448
    [Abstract] [Full Text] [Related]

  • 16. The distinct role of strand-specific miR-514b-3p and miR-514b-5p in colorectal cancer metastasis.
    Ren LL, Yan TT, Shen CQ, Tang JY, Kong X, Wang YC, Chen J, Liu Q, He J, Zhong M, Chen HY, Hong J, Fang JY.
    Cell Death Dis; 2018 Jun 07; 9(6):687. PubMed ID: 29880874
    [Abstract] [Full Text] [Related]

  • 17. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
    Fang Z, Tang J, Bai Y, Lin H, You H, Jin H, Lin L, You P, Li J, Dai Z, Liang X, Su Y, Hu Q, Wang F, Zhang ZY.
    J Exp Clin Cancer Res; 2015 Aug 22; 34(1):86. PubMed ID: 26297223
    [Abstract] [Full Text] [Related]

  • 18. Expression Analysis of Previously Verified Fecal and Plasma Dow-regulated MicroRNAs (miR-4478, 1295-3p, 142-3p and 26a-5p), in FFPE Tissue Samples of CRC Patients.
    Ghanbari R, Rezasoltani S, Hashemi J, Mohamadkhani A, Tahmasebifar A, Arefian E, Mobarra N, Asadi J, Nazemalhosseini Mojarad E, Yazdani Y, Knuutila S, Malekzadeh R.
    Arch Iran Med; 2017 Feb 22; 20(2):92-95. PubMed ID: 28193082
    [Abstract] [Full Text] [Related]

  • 19. The tumor suppressor miR-138-5p targets PD-L1 in colorectal cancer.
    Zhao L, Yu H, Yi S, Peng X, Su P, Xiao Z, Liu R, Tang A, Li X, Liu F, Shen S.
    Oncotarget; 2016 Jul 19; 7(29):45370-45384. PubMed ID: 27248318
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA miR-29a Inhibits Colon Cancer Progression by Downregulating B7-H3 Expression: Potential Molecular Targets for Colon Cancer Therapy.
    Wang J, Chen X, Xie C, Sun M, Hu C, Zhang Z, Luan L, Zhou J, Zhou J, Zhu X, Ouyang J, Dong X, Li D, Zhang J, Zhao X.
    Mol Biotechnol; 2021 Sep 19; 63(9):849-861. PubMed ID: 34100183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.